Back to BlackRock, Inc. BlackRock, Inc.

KALVKALV
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in KALVISTA PHARMACEUTICALS INC

BlackRock, Inc. previously held 0 shares of KALV (KALVISTA PHARMACEUTICALS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$24.3M

Total Shares Change

-2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$27.00
0
2026-Q1
Increased
3.8M
+1.1%
$76.4M0.0%$15.61
30
2025-Q4
Increased
3.8M
+20.1%
$60.6M0.0%$15.68
35
2025-Q3
Decreased
3.1M
-0.1%
$38.1M0.0%$12.21
0
2025-Q2
Decreased
3.1M
-0.7%
$35.4M0.0%$11.41
0
2025-Q1
Increased
3.2M
+10.1%
$36.4M0.0%$11.93
32
2024-Q4
New
2.9M
-
$24.3M0.0%$8.39
40

Other major holders of KALV: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors, MILLENNIUM MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used